nature publishing group in the future to answer many challenging questions (donor selection, patient selection, number and length of FMT therapy required, and so on) with respect to the clinical application of this treatment.
To the Editor: Complex bacteriotherapy, such as fecal microbiota transplantation (FMT), is an emerging therapeutic modality for ulcerative colitis (UC) ( 1 ) . FMT has been implicated in facilitating the withdrawal of conventional therapies in select patients ( 2 ) . In our study, three immunotherapy (infl iximab, 6-mercaptopurine, and steroid, respectively)-dependent pediatric (14-16 years of age) UC patients ( Filtered, frozen, and thawed stool specimens from a standardized single donor (a 37-year-old man) for all three patients was used, which provided a unique opportunity for examining microbial changes. Patients were concomitantly withdrawn from their conventional medications. Mucosal disease activity was assessed before and 2 weeks aft er the FMT series. Clinical disease activity was followed by the Pediatric Ulcerative Colitis Activity Index (PUCAI). Th e FMT series was well tolerated and transiently supported immunotherapy withdrawal ( Supplementary Figure 1 online) . FMT enabled all three patients to be symptomfree for at least 4 weeks following FMT and supported the withdrawal of immunotherapy (no treatment other than mesalamine) for more than 105 days in all. Th e number of FMT treatments signifi cantly correlated with the time of being immunotherapy-free ( r =0.998, P =0.04; Supplementary Figure 2 ). All patients were in endoscopic and histologic remission 2 weeks aft er the last FMT ( Supplementary  Figures 3-4 ) .
Fecal microbiomes were analyzed by massively parallel pyrosequencing of the V3V5 regions within the bacterial 16S rRNA gene. Th e nature of microbiota shift s diff ered, presumably because of differences in baseline composition of intestinal microbiota in each patient (detected by principal-coordinates-analysis, Figure  1a ). Recipient microbiomes remained distinct from that of the anonymous donor. Table 1 ). Six of 8 OTUs that increased in abundance were not detected in the donor or the recipient prior to FMT. Th erefore, expansion of rare taxa may be functionally important in restoring colonic health, at least for short-term periods, following FMT. Of the OTUs that were increased in abundance 61.5% belonged to the Lachnospiraceae family. Th e abundance of Lachnospiraceae has been inversely correlated with UC disease activity ( 3 ), and those were more abundant in healthy members of monozygotic twin pairs discordant for UC, compared with control ( 4 ). At the genus level, only Coprococcus changed (increased) in abundance by more than twofold. Th e abundance of Coprococcus (a genus including butyrateproducing bacteria) has been found to be decreased in infl ammatory bowel disorder (IBD) patients ( 5 ) . Th erefore, the increased abundance of Coprococcus and Lachnospiraceae upon the FMT series may have delivered benefi cial eff ects to the colonic epithelium of the UC patients (recipients).
Colonic mucosal gene expression profi les in response to the FMT series were studied by RNA sequencing. Th e expression of 742 genes decreased and that of 12 increased (>1.5-fold change in expression, false discovery rate<0.05) upon FMT therapy ( Supplementary Table 2-3 ). Importantly, the suppression of human gene expression relevant in leukocyte activation and mitotic cell cycle progression was observed ( Supplementary Figure 6-7 ) . Th ese molecular fi ndings were associated with >50% decline in epithelial cell mitosis in two out of the three patients ( Supplementary Figure 8 ) .
In conclusion, this report describes highintensity FMT as a strategy to reset the intestinal microbiota in pediatric IBD. Serial FMT in pediatric UC may induce benefi cial changes in patient microbiota and colonic mucosa. Randomized trials will be required . Principle coordinates analysis of unweighted Unifrac distances ( a ) revealed that microbial community changes during FMT (arrows connect pre-FMT (within 24 h before fi rst FMT) and post-FMT (2-3 weeks after last FMT) samples from each patient) were not consistent within each patient (did not shift in the same direction for each patient), and post-FMT fecal communities of recipients (patients) following FMT were dissimilar from that of the donor (▲: donor stool; ■: donor preparations from independent bowel movements on separate days). Microbial richness ( b ) and diversity ( c ) in terms of microbial taxa consistently increased following the FMT, although these trends did not reach statistical signifi cance. OTU, operational taxonomic units.
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